Condition: Venous Thromboses · Thromboembolic Disease · Neutrophil Extracellular Trap Formation · Sponsor: University Hospital, Bordeaux
Thrombo-embolic venous diseases are represented by deep venous thrombosis and/or pulmonary embolism. In some patients with repeated thrombosis or occurrence of thrombosis in unusual sites, the etiological workup remains negative, which represents a problem for the management of the anticoagulant treatments. Recently, two factors have been identified as important in the physiopathology of hemostasis and coagulation: the presence of clonal hematopoiesis of indetermined potential (CHIP) and the formation of neutrophil extracellular traps (NETs). In this study, these two factors will be studied in patients with repeated venous thrombosis or thrombosis occurring in unusual site.
This description comes directly from the study's public registry record.
Alexandre GUY · 0557656478 · alexandre.guy@chu-bordeaux.fr
Chloé JAMES · 0557891979 · chloe.james@chu-bordeaux.fr
Always discuss trial participation with your own doctor first.
| CHU de Bordeaux, Service de Neurologie | Bordeaux, France | Not Yet Recruiting |
| CHU de Bordeaux, Service Gastro-Entérologie | Bordeaux, France | Not Yet Recruiting |
| CHU de Bordeaux, Service Hématologie Biologique | Bordeaux, France | Recruiting |
| CHU de Bordeaux, Service Médecine Vasculaire | Bordeaux, France | Recruiting |
| CHU de Bordeaux, Unité ambulatoire de Médecine Vasculaire | Bordeaux, France | Recruiting |
| CHU de Lille, Service Hémostase Clinique | Lille, France | Not Yet Recruiting |
| APHM - Hôpital de la Timone, Service Hématologie | Marseille, France | Not Yet Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05711173